Maiden Biosciences, Inc

Incorporated in 1989, Otsuka America Pharmaceutical is a health care company that commercializes its products throughout North America. It offers products under the ABILIFY Tablets1 and PLETAL Tablets2 brands. The company works in collaboration with Bristol-Myers Squibb, which co-develops and co-promotes ABILIFY. Otsuka America Pharmaceutical has also merged with Meretek Diagnostics to form the Meretek Diagnostics Group under the Medical Device Division of OAPI. It focuses on neuroscience, cardiovascular, oncologic and gastrointestinal therapeutic treatments. The company operates Otsuka Maryland Research Institute, which was established as a wholly-owned subsidiary of OAPI to research and develop a variety of health care products. Otsuka America Pharmaceutical is a part of Otsuka Pharmaceutical Group.

LKC Technologies, based in Gaithersburg, MD, specializes in functional eye testing solutions for both human and veterinary applications. With over 45 years of experience, the company offers innovative devices like the handheld RETeval ERG/VEP device, which aids in diagnosing and managing various retinal conditions by providing objective results without the need for corneal contact. The company's products, including the RETevet for veterinary ophthalmologists and researchers, enable comprehensive assessments of retinal function, enhancing diagnostic accuracy and patient outcomes. LKC Technologies is committed to advancing the field of electrophysiology through reliable, user-friendly testing solutions that support clinicians and researchers alike. Generated from the website